NCT02818946

Brief Summary

The purpose of the proposed prospective study is to determine the diagnostic value of MRI for the evaluation of patients with pathologic nipple discharge. Breast surgeons will identify clinic patients with pathologic nipple discharge (unilateral and bloody or unilateral and clear) and refer them for breast MRI. When the clinical team notifies the study team that an MRI has been ordered for that purpose, the study team will consent patients to document the results and follow-up. The study team will not be obtaining MRI's on patients for research purposes only. The following data will be collected and analyzed: patient age, characteristics of the discharge (laterality, spontaneous versus expressed, duration of time, color, presence of blood), imaging workup and findings, BI-RADS final assessment categories, pathology results from core biopsy and/or surgical excision, and clinical and radiologic follow-up data during the two years after presentation. Participation in this study poses minimal risk to patients. Risks to the subjects include loss of confidentiality and unnecessary breast biopsy. The risks associated with MRI are minimal; however, since a gadolinium-based contrast agent will be administered for the MRI, patients with compromised renal function and patients who are pregnant will be excluded from the study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 30, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2019

Completed
5 months until next milestone

Results Posted

Study results publicly available

January 7, 2020

Completed
Last Updated

January 7, 2020

Status Verified

December 1, 2019

Enrollment Period

3.1 years

First QC Date

June 28, 2016

Results QC Date

December 20, 2019

Last Update Submit

December 20, 2019

Conditions

Keywords

MRISpontaneous Nipple DischargeBreast Cancer

Outcome Measures

Primary Outcomes (4)

  • Sensitivity

    Sensitivity of MRI in detecting breast cancer in women with pathologic nipple discharge. \[Number of patients with positive MRIs confirmed with biopsy / (Number of patients with positive MRIs confirmed with biopsy + Number of patients with negative MRIs who present within 1 year with breast cancer)\]

    Day 1

  • Specificity

    Specificity of MRI in detecting breast cancer in women with pathologic nipple discharge. \[Number of patients with negative MRIs / (Number of patients with negative MRIs + Number of patients with positive MRIs but with benign biopsy)\]

    Day 1

  • Positive Predictive Value

    Positive Predictive Value of MRI in detecting breast cancer in women with pathologic nipple discharge. \[Number of patients with positive MRIs confirmed with biopsy / (Number of patients with positive MRIs confirmed with biopsy + Number of patients with positive MRIs but with benign biopsy)\]

    Day 1

  • Negative Predictive Value

    Negative Predictive Value of MRI in detecting breast cancer in women with pathologic nipple discharge. \[Number of patients with negative MRIs / (Number of patients with negative MRIs + Number of patients with negative MRIs who present within 1 year with breast cancer)\]

    Day 1

Study Arms (1)

MRI

OTHER

Patients who have undergone mammography, breast sonography, and planning to have a contrast-enhanced breast MRI for evaluation of nipple discharge.

Device: MRI

Interventions

MRIDEVICE

Detection of cancer by MRI for pathologic nipple discharge

MRI

Eligibility Criteria

Age22 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female patients with unilateral and bloody nipple discharge OR unilateral and clear nipple discharge
  • clinical decision to have contrast enhanced MRI

You may not qualify if:

  • male gender
  • non-English speakers
  • age \< 21 years
  • lack of capacity to give legally effective consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Related Publications (18)

  • Kooistra BW, Wauters C, van de Ven S, Strobbe L. The diagnostic value of nipple discharge cytology in 618 consecutive patients. Eur J Surg Oncol. 2009 Jun;35(6):573-7. doi: 10.1016/j.ejso.2008.09.009. Epub 2008 Nov 4.

    PMID: 18986790BACKGROUND
  • Lorenzon M, Zuiani C, Linda A, Londero V, Girometti R, Bazzocchi M. Magnetic resonance imaging in patients with nipple discharge: should we recommend it? Eur Radiol. 2011 May;21(5):899-907. doi: 10.1007/s00330-010-2009-y. Epub 2010 Nov 30.

    PMID: 21116634BACKGROUND
  • Fisher CS, Margenthaler JA. A look into the ductoscope: its role in pathologic nipple discharge. Ann Surg Oncol. 2011 Oct;18(11):3187-91. doi: 10.1245/s10434-011-1962-2. Epub 2011 Aug 23.

    PMID: 21861230BACKGROUND
  • Hussain AN, Policarpio C, Vincent MT. Evaluating nipple discharge. Obstet Gynecol Surv. 2006 Apr;61(4):278-83. doi: 10.1097/01.ogx.0000210242.44171.f6.

    PMID: 16551379BACKGROUND
  • Rissanen T, Reinikainen H, Apaja-Sarkkinen M. Breast sonography in localizing the cause of nipple discharge: comparison with galactography in 52 patients. J Ultrasound Med. 2007 Aug;26(8):1031-9. doi: 10.7863/jum.2007.26.8.1031.

    PMID: 17646365BACKGROUND
  • Sabel MS, Helvie MA, Breslin T, Curry A, Diehl KM, Cimmino VM, Chang AE, Newman LA. Is duct excision still necessary for all cases of suspicious nipple discharge? Breast J. 2012 Mar-Apr;18(2):157-62. doi: 10.1111/j.1524-4741.2011.01207.x. Epub 2011 Dec 30.

    PMID: 22211878BACKGROUND
  • Bahl M, Baker JA, Greenup RA, Ghate SV. Diagnostic Value of Ultrasound in Female Patients With Nipple Discharge. AJR Am J Roentgenol. 2015 Jul;205(1):203-8. doi: 10.2214/AJR.14.13354.

    PMID: 26102400BACKGROUND
  • Gray RJ, Pockaj BA, Karstaedt PJ. Navigating murky waters: a modern treatment algorithm for nipple discharge. Am J Surg. 2007 Dec;194(6):850-4; discussion 854-5. doi: 10.1016/j.amjsurg.2007.08.027.

    PMID: 18005783BACKGROUND
  • Morrogh M, Park A, Elkin EB, King TA. Lessons learned from 416 cases of nipple discharge of the breast. Am J Surg. 2010 Jul;200(1):73-80. doi: 10.1016/j.amjsurg.2009.06.021. Epub 2010 Jan 15.

    PMID: 20079481BACKGROUND
  • Orel SG, Dougherty CS, Reynolds C, Czerniecki BJ, Siegelman ES, Schnall MD. MR imaging in patients with nipple discharge: initial experience. Radiology. 2000 Jul;216(1):248-54. doi: 10.1148/radiology.216.1.r00jn28248.

    PMID: 10887256BACKGROUND
  • Morrogh M, Morris EA, Liberman L, Borgen PI, King TA. The predictive value of ductography and magnetic resonance imaging in the management of nipple discharge. Ann Surg Oncol. 2007 Dec;14(12):3369-77. doi: 10.1245/s10434-007-9530-5. Epub 2007 Sep 26.

    PMID: 17896158BACKGROUND
  • Lubina N, Schedelbeck U, Roth A, Weng AM, Geissinger E, Honig A, Hahn D, Bley TA. 3.0 Tesla breast magnetic resonance imaging in patients with nipple discharge when mammography and ultrasound fail. Eur Radiol. 2015 May;25(5):1285-93. doi: 10.1007/s00330-014-3521-2. Epub 2014 Nov 30.

    PMID: 25433415BACKGROUND
  • Nakahara H, Namba K, Watanabe R, Furusawa H, Matsu T, Akiyama F, Sakamoto G, Tamura S. A comparison of MR imaging, galactography and ultrasonography in patients with nipple discharge. Breast Cancer. 2003;10(4):320-9. doi: 10.1007/BF02967652.

    PMID: 14634510BACKGROUND
  • van Gelder L, Bisschops RH, Menke-Pluymers MB, Westenend PJ, Plaisier PW. Magnetic resonance imaging in patients with unilateral bloody nipple discharge; useful when conventional diagnostics are negative? World J Surg. 2015 Jan;39(1):184-6. doi: 10.1007/s00268-014-2701-1.

    PMID: 25123174BACKGROUND
  • Ballesio L, Maggi C, Savelli S, Angeletti M, De Felice C, Meggiorini ML, Manganaro L, Porfiri LM. Role of breast magnetic resonance imaging (MRI) in patients with unilateral nipple discharge: preliminary study. Radiol Med. 2008 Mar;113(2):249-64. doi: 10.1007/s11547-008-0245-x. Epub 2008 Apr 2. English, Italian.

    PMID: 18386126BACKGROUND
  • Manganaro L, D'Ambrosio I, Gigli S, Di Pastena F, Giraldi G, Tardioli S, Framarino M, Porfiri LM, Ballesio L. Breast MRI in patients with unilateral bloody and serous-bloody nipple discharge: a comparison with galactography. Biomed Res Int. 2015;2015:806368. doi: 10.1155/2015/806368. Epub 2015 Jan 22.

    PMID: 25685810BACKGROUND
  • Simmons R, Adamovich T, Brennan M, Christos P, Schultz M, Eisen C, Osborne M. Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol. 2003 Mar;10(2):113-6. doi: 10.1245/aso.2003.03.089.

    PMID: 12620904BACKGROUND
  • Sakorafas GH. Nipple discharge: current diagnostic and therapeutic approaches. Cancer Treat Rev. 2001 Oct;27(5):275-82. doi: 10.1053/ctrv.2001.0234.

    PMID: 11871863BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Results Point of Contact

Title
Sujata Ghate, MD
Organization
Duke University

Study Officials

  • Sujata Ghate, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2016

First Posted

June 30, 2016

Study Start

July 1, 2016

Primary Completion

August 6, 2019

Study Completion

August 6, 2019

Last Updated

January 7, 2020

Results First Posted

January 7, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations